Motif Bio to Present Iclaprim Data at Upcoming Scientific Conferences

September 20, 2018
Motif Bio plc

Motif Bio plc (AIM/NASDAQ: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced that iclaprim data will be presented at two upcoming scientific conferences: IDWeek 2018 and World Anti-Microbial Resistance Congress.

More information available here: